Eli Lilly and Company (LLY) is listed on NYSE in Pharmaceutical Stocks. It is $1,173.34, -0.23%, with a $1.1T market cap. RSI is 46.3, neutral. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 46.3 Neutral
Market Cap $1.1T
Volume 1.6M
Fundamentals — 10-Q Q2 2026
Revenue $42.8B
Net Income $14.5B
EPS $16.19
Gross Margin 84.0%
Net Margin 33.9%
Debt / Equity 1.4x
P/E Ratio 72.5x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Jonsson Patrik | EVP & President, LLY Int'l | Sell | 6,500 | $1175.10 | $7.6M | 2026 Aug 17 |
| Zakrowski Donald A | SVP, Finance, & CAO | Sell | 2,000 | $1185.01 | $2.4M | 2026 Aug 10 |
| Hakim Anat | EVP, GC & Secretary | Sell | 5,000 | $1190.00 | $6.0M | 2026 Aug 7 |
| Yuffa Ilya | EVP&Pres, LLY USA&Global Capab | Sell | 2,500 | $1150.77 | $2.9M | 2026 Jun 10 |
| Lilly Endowment Inc | Insider | Sell | 15,828 | $995.36 | $15.8M | 2026 May 6 |
| Lilly Endowment Inc | 10% Owner | Sell | 3,593 | $1085.04 | $3.9M | 2025 Dec 29 |
| Lilly Endowment Inc | 10% Owner | Sell | 2,629 | $1085.17 | $2.9M | 2025 Dec 24 |
| Lilly Endowment Inc | 10% Owner | Sell | 240 | $1085.04 | $260,410 | 2025 Dec 23 |
| Lilly Endowment Inc | 10% Owner | Sell | 15,632 | $1109.30 | $17.3M | 2025 Nov 25 |
| Lilly Endowment Inc | 10% Owner | Sell | 147,061 | $1095.35 | $161.1M | 2025 Nov 25 |
| Lilly Endowment Inc | 10% Owner | Sell | 142,307 | $1068.53 | $152.1M | 2025 Nov 24 |
| Lilly Endowment Inc | 10% Owner | Sell | 105,326 | $1058.66 | $111.5M | 2025 Nov 21 |
| Lilly Endowment Inc | 10% Owner | Sell | 37,148 | $1051.66 | $39.1M | 2025 Nov 20 |
| Lilly Endowment Inc | 10% Owner | Sell | 167,526 | $1051.17 | $176.1M | 2025 Nov 19 |
| Lilly Endowment Inc | 10% Owner | Sell | 60,213 | $1034.78 | $62.3M | 2025 Nov 18 |
| Lilly Endowment Inc | 10% Owner | Sell | 9,886 | $1030.68 | $10.2M | 2025 Nov 17 |
| Lilly Endowment Inc | 10% Owner | Sell | 178,295 | $425738.48 | $75907.0M | 2025 Nov 14 |
| Lilly Endowment Inc | 10% Owner | Sell | 46,606 | $1030.26 | $48.0M | 2025 Nov 13 |
| Zakrowski Donald A | SVP, Finance, & CAO | Sell | 1,000 | $1010.50 | $1.0M | 2025 Nov 13 |
| Lilly Endowment Inc | 10% Owner | Sell | 305,000 | $1011.19 | $308.4M | 2025 Nov 12 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $255.53 | 48.7 | $451.6B |
| | $244.60 | 46.0 | $15.9B |
| | $112.44 | 58.9 | $195.8B |
| | $27.96 | 64.8 | $159.3B |
| | $794.08 | 58.2 | $82.1B |
| | $45.60 | 41.8 | -- |
Take LLY further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put LLY in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Eli Lilly and Company next reports.
Set alerts on LLY
Get notified when Eli Lilly and Company hits your price targets or technical conditions are met.
Get Started Free